Partnership Aims to Develop Next-Generation Pacemakers and Stem Cell Pump


July 15, 2013

Leonhardt Ventures and Core Manufacturing LLC announced its partnership in June 2013 to manufacture and bring to market a lineup of medical technologies, including:

  • MyoStim Heart Pacer: The first heart pacemaker designed to recruit reparative stem cells to damaged or weakened heart tissue via a homing signal. The recruited stem cells are converted to working heart muscle.
  • Stem Cell Pump: The first implantable, wirelessly recharged pump designed to deliver controlled dosages of stem cells and growth factors to selected organs for recovery and repair.
  • AortaCell: First noninvasive device that focuses electrical energy wirelessly onto weakened aortic vessel walls to recruit stem cells and convert those cells into smooth muscle to repair an aortic aneurysm without surgery or intervention. This wireless electrical energy/stem cell technology will be the basis of a number of follow-on developments by this team.
  • CoroStim: The first vibrational-energy-emitting pacemaker add-on designed to prevent arterial plaque formation in high-risk patients.

Under the new agreement, Core Manufacturing will provide manufacturing services for active implantable devices on behalf of Leonhardt Ventures' portfolio of companies and developments. Core Manufacturing is a unique resource for OEMs looking for commercialization of complex medical devices, with capabilities that include rapid-turn prototyping and full turnkey device-level assembly, sterilization and testing, specializing in active implantable devices.

For more information: